GENNEX LABORATORIES
Back to Income Statement
|
GENNEX LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹18 Cr | ₹11 Cr | ₹6.19 Cr | ₹4.11 Cr | ₹4.04 Cr |
What is the latest Consolidated Net Profit of GENNEX LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹18 Cr |
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹6.19 Cr |
| Mar2023 | ₹4.11 Cr |
| Mar2022 | ₹4.04 Cr |
How is Consolidated Net Profit of GENNEX LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹18 Cr | 59.35 | |
| Mar2025 | ₹11 Cr | 83.61 | |
| Mar2024 | ₹6.19 Cr | 50.89 | |
| Mar2023 | ₹4.11 Cr | 1.66 | |
| Mar2022 | ₹4.04 Cr | - | |
Compare Consolidated Net Profit of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹223.2 Cr | 2.1% | -0.2% | -36.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | 2.1% |
-0.2% |
-36.6% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses